Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Central nervous system multiple myeloma: a different cytogenetic profile.
Gozzetti A, Frasconi A, Crupi R, Candi V, Defina M, Bocchia M. Gozzetti A, et al. Among authors: candi v. Br J Haematol. 2014 Jun;165(6):889-90. doi: 10.1111/bjh.12812. Epub 2014 Feb 26. Br J Haematol. 2014. PMID: 24571330 Free article. No abstract available.
Chemoimmunotherapy with oral low-dose fludarabine, cyclophosphamide and rituximab (old-FCR) as treatment for elderly patients with chronic lymphocytic leukaemia.
Gozzetti A, Candi V, Fabbri A, Schiattone L, Cencini E, Lauria F, Frasconi A, Crupi R, Raspadori D, Papini G, Defina M, Bartalucci G, Bocchia M. Gozzetti A, et al. Among authors: candi v. Leuk Res. 2014 Aug;38(8):891-5. doi: 10.1016/j.leukres.2014.05.016. Epub 2014 Jun 2. Leuk Res. 2014. PMID: 24934847
Plasmablastic transformation of a pre-existing plasmacytoma: a possible role for reactivation of Epstein Barr virus infection.
Ambrosio MR, De Falco G, Gozzetti A, Rocca BJ, Amato T, Mourmouras V, Gazaneo S, Mundo L, Candi V, Piccaluga PP, Cusi MG, Leoncini L, Lazzi S. Ambrosio MR, et al. Among authors: candi v. Haematologica. 2014 Nov;99(11):e235-7. doi: 10.3324/haematol.2014.111872. Epub 2014 Sep 5. Haematologica. 2014. PMID: 25193957 Free PMC article. No abstract available.
Therapeutic advancements in multiple myeloma.
Gozzetti A, Candi V, Papini G, Bocchia M. Gozzetti A, et al. Among authors: candi v. Front Oncol. 2014 Sep 4;4:241. doi: 10.3389/fonc.2014.00241. eCollection 2014. Front Oncol. 2014. PMID: 25237651 Free PMC article. Review.
Intravenous (IV) bortezomib infusion after non-response to subcutaneous bortezomib administration can induce transitory responses in multiple myeloma patients: are some patients more sensitive to IV bortezomib?
Gozzetti A, Candi V, Zuanelli Brambilla C, Papini G, Bocchia M. Gozzetti A, et al. Among authors: candi v. Br J Haematol. 2017 Apr;177(1):144-147. doi: 10.1111/bjh.14032. Epub 2016 Mar 11. Br J Haematol. 2017. PMID: 26970245 Free article. No abstract available.
Second Generation Proteasome Inhibitors in Multiple Myeloma.
Gozzetti A, Papini G, Candi V, Brambilla CZ, Sirianni S, Bocchia M. Gozzetti A, et al. Among authors: candi v. Anticancer Agents Med Chem. 2017;17(7):920-926. doi: 10.2174/1871520616666160902101622. Anticancer Agents Med Chem. 2017. PMID: 27592543 Review.
14 results